Status:
UNKNOWN
Self-controlled Study Between 4-hour and 24-hour Delayed Radiographs in HSG Using OSCM
Lead Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Collaborating Sponsors:
Jiangsu Hengrui Pharmaceutical Co., Ltd.
Conditions:
Infertility
Eligibility:
FEMALE
21-38 years
Phase:
NA
Brief Summary
Background of the study: Hysterosalpingography (HSG) is widely used for the female infertility workup. Many studies have demonstrated that the use of oil-soluble contrast medium (OSCM) ethiodized oil...
Eligibility Criteria
Inclusion
- Having spontaneous ovulation or inducing ovulation;
- Infertility lasting for 12 months;
- Conforms to the indications of hysterosalpingography;
- Understand and sign the informed consent;
Exclusion
- Iodine allergy or hyperthyroidism
- Acute genital tract inflammation or abnormal leucorrhea examination;
- Abnormal vaginal bleeding;
- Fever or preoperative temperature higher than 37.5℃ within 3 days before angiography;
- Severe insufficiency of cardiopulmonary or liver function;
- During pregnancy and menstruation;
- With complications that may cause subjects to be unable to follow the study plan or even endanger the patient's safety or social environment;
- Patients who are participating in other clinical studies or who are not suitable for inclusion in this study due to other reasons considered by the researchers.
Key Trial Info
Start Date :
October 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04744610
Start Date
October 22 2020
End Date
March 1 2021
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China